Soomin Yoon
Overview
Explore the profile of Soomin Yoon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
51
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yoon J, Jung J, Park B, Lee E, Park Y, Yoon S, et al.
BMC Cancer
. 2025 Feb;
25(1):369.
PMID: 40022009
Background: The treatment landscape for multiple myeloma (MM) has significantly progressed in recent decades. Methods: We analyzed the treatment patterns and clinical outcomes in Korean patients using data from the...
2.
Koh Y, Yoon S, Kim K, Lee J, Jung S, Yoon S, et al.
Cancer Res Treat
. 2024 Dec;
PMID: 39727014
Purpose: Daratumumab is a novel, first-in-class monoclonal antibody approved for use as monotherapy and in combination with other treatments for patients with multiple myeloma (MM). The aim of this observational...
3.
Park J, Kim N, Jung K, Yoon S, Noh S, Bang J, et al.
Polymers (Basel)
. 2021 Oct;
13(19).
PMID: 34641112
Silica nanoparticles (G-SiNPs) blocked with 3-glycidoxypropyl trimethoxysilane (GPTS) were newly applied to hydrogel films for improving film coating properties and to distribute the epoxy groups on the film surface. The...
4.
Han J, Lee J, Park S, Yoon S, Yoon A, Hwang D, et al.
Exp Mol Med
. 2016 Nov;
48(11):e271.
PMID: 27857068
The C-terminal domain of RNA polymerase II is an unusual series of repeated residues appended to the C-terminus of the largest subunit and serves as a flexible binding scaffold for...
5.
Choi Y, Yoon S, Kim K, Yoo J, Song P, Kim M, et al.
PLoS One
. 2014 Apr;
9(4):e92513.
PMID: 24710267
We developed a process to produce novel interactions between two previously unrelated proteins. This process selects protein scaffolds and designs protein interfaces that bind to a surface patch of interest...
6.
Kim H, Yoon S, Chung J
BMB Rep
. 2014 Feb;
47(3):130-4.
PMID: 24499668
The combination of a high-affinity antibody to a hapten, and hapten-conjugated compounds, can provide an alternative to the direct chemical cross-linking of the antibody and compounds. An optimal hapten for...
7.
Yoon S, Kim Y, Kang S, Kim S, Lee H, Kim H, et al.
J Cancer Res Clin Oncol
. 2013 Dec;
140(2):227-33.
PMID: 24292501
Purpose: Cotinine has optimal characteristics as a hapten for pre-targeted radioimmunotherapy (PRIT). This study was performed to evaluate the applicability of cotinine/anti-cotinine antibody to PRIT. Methods: We developed and prepared...
8.
Kim M, Yoon S, Lee S, Ha S, Kim H, Kim J, et al.
PLoS One
. 2012 Apr;
7(4):e35100.
PMID: 22514712
Gremlin-1, a bone morphogenetic protein (BMP) antagonist, is overexpressed in various cancerous tissues but its role in carcinogenesis has not been established. Here, we report that gremlin-1 binds various cancer...